SCNX MEXC RealStocks
Own real SCNX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:04:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Scienture Holdings, Inc. (SCNX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.39, with a market capitalization of $4.91M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.32 to $18.75. This page covers its latest market performance, valuation, price trends and company information.
$4.91M | |
$2.80 | |
$3.17 | |
$2.32 | |
$2.76 | |
91.04K | |
157.15K | |
-- | |
$18.75 | |
$2.32 | |
-- | |
2026-06-30 |
Scienture Holdings, Inc. (SCNX) last closed at $2.39 as of 2026-11-19 00:38:00, down 2.90% ($0.08) from the previous close of $2.76.
During the latest regular trading session, SCNX traded between $2.32 and $3.17, with a volume of 91.04K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Scienture Holdings, Inc. (SCNX) moved from $3.20 to $2.39, representing a decline of 25.47% ($0.82).
The stock traded between $2.32 and $3.27 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 21.07 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.4%
SCNX is currently trading at $2.39, placing it 0.4% of the way from its 52-week low of $2.32 to its 52-week high of $18.75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 9 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Scienture Holdings, Inc. (SCNX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to SCNX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between SCNX shares and USD.
SCNX Shares to USD
1.00 SCNX shares = 2.385 USD
Calculations are estimates based on the latest available price and are for reference only.